Notice Pursuant to the National Cooperative Research and Production Act of 1993-Open Source Imaging Consortium, Inc., 28152 [2021-10926]

Download as PDF 28152 Federal Register / Vol. 86, No. 99 / Tuesday, May 25, 2021 / Notices in the collection of data related to pricing or other commercial terms. Register pursuant to Section 6(b) of the Act on January 28, 2021 (86 FR 7416). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2021–10934 Filed 5–24–21; 8:45 am] [FR Doc. 2021–10925 Filed 5–24–21; 8:45 am] BILLING CODE 4410–11–P BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–839] Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division jbell on DSKJLSW7X2PROD with NOTICES Notice Pursuant to The National Cooperative Research and Production Act of 1993—Border Security Technology Consortium Notice is hereby given that, on April 23, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Border Security Technology Consortium (‘‘BSTC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Colvin Run Networks Inc., Leesburg, VA; DroneShield LLC, Warrenton, VA; Pyramid Systems, Inc., Fairfax, VA; and Raytheon Company, Waltham, MA have been added as parties to this venture. Also, Gatekeeper Inc., Sterling, VA; Hamilton Sundstrand Corporation, San Dimas, CA; Land Sea Air Autonomy, Finksburg, MD; Mobilestack Inc, Dublin, CA; and Priority 5 Holdings, Inc., Needham, MA have withdrawn as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and BSTC intends to file additional written notifications disclosing all changes in membership. On May 30, 2012, BSTC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 18, 2012 (77 FR 36292). The last notification was filed with the Department on January 12, 2021. A notice was published in the Federal Notice Pursuant to the National Cooperative Research and Production Act of 1993—Open Source Imaging Consortium, Inc. Notice is hereby given that, on May 5, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Open Source Imaging Consortium, Inc. (‘‘Open Source Imaging Consortium’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Pavilhao Pereira Filho Hospital, Porto Alegre, BRAZIL; Medical University of Vienna, Vienna, AUSTRIA; Royal Brompton Hospital, London, UNITED KINGDOM; The Research Institute of St. Joseph’s, Ontario, CANADA; and Thirona B.V., Nijmegen, NETHERLANDS have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Open Source Imaging Consortium intends to file additional written notifications disclosing all changes in membership. On March 20, 2019, Open Source Imaging Consortium filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on April 12, 2019 (84 FR 14973). The last notification was filed with the Department on February 4, 2021. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on March 10, 2021 (86 FR 13751). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2021–10926 Filed 5–24–21; 8:45 am] BILLING CODE 4410–11–P VerDate Sep<11>2014 18:09 May 24, 2021 Jkt 253001 PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 26, 2021. Such persons may also file a written request for a hearing on the application on or before July 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on March 31, 2021, American Radiolabeled Chem, 101 Arc Drive, Saint Louis, Missouri 63146– 3502, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: SUMMARY: Controlled substance Gamma Hydroxybutyric Acid Ibogaine ................................ Lysergic acid diethylamide ... Tetrahydrocannabinols ......... Dimethyltryptamine ............... 1-[1-(2-Thienyl) cyclohexyl]piperidine. Dihydromorphine ................... Heroin ................................... Normorphine ......................... Amphetamine ........................ Methamphetamine ................ Amobarbital ........................... Phencyclidine ........................ Phenylacetone ...................... Cocaine ................................. Codeine ................................. Dohydrocodeine .................... Oxycodone ............................ Hydromorphone .................... Ecgonine ............................... Hydrocodone ......................... Meperidine ............................ Metazocine ............................ Methadone ............................ Dextropropoxyphene, bulk (non-dosage forms). Morphine ............................... Oripavine ............................... E:\FR\FM\25MYN1.SGM 25MYN1 Drug code Schedule 2010 7260 7315 7370 7435 7470 I I I I I I 9145 9200 9313 1100 1105 2125 7471 8501 9041 9050 9120 9143 9150 9180 9193 9230 9240 9250 9273 I I I II II II II II II II II II II II II II II II II 9300 9330 II II

Agencies

[Federal Register Volume 86, Number 99 (Tuesday, May 25, 2021)]
[Notices]
[Page 28152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10926]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Open Source Imaging Consortium, Inc.

    Notice is hereby given that, on May 5, 2021, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Open Source Imaging Consortium, 
Inc. (``Open Source Imaging Consortium'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Pavilhao Pereira 
Filho Hospital, Porto Alegre, BRAZIL; Medical University of Vienna, 
Vienna, AUSTRIA; Royal Brompton Hospital, London, UNITED KINGDOM; The 
Research Institute of St. Joseph's, Ontario, CANADA; and Thirona B.V., 
Nijmegen, NETHERLANDS have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Open Source Imaging Consortium 
intends to file additional written notifications disclosing all changes 
in membership.
    On March 20, 2019, Open Source Imaging Consortium filed its 
original notification pursuant to Section 6(a) of the Act. The 
Department of Justice published a notice in the Federal Register 
pursuant to Section 6(b) of the Act on April 12, 2019 (84 FR 14973).
    The last notification was filed with the Department on February 4, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on March 10, 2021 (86 FR 13751).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-10926 Filed 5-24-21; 8:45 am]
BILLING CODE 4410-11-P